Date | Price Target | Rating | Analyst |
---|---|---|---|
8/7/2024 | $49.00 → $52.00 | Hold → Buy | Deutsche Bank |
11/6/2023 | $46.00 → $37.00 | Buy → Hold | Deutsche Bank |
2/16/2023 | $50.00 | Perform → Outperform | Oppenheimer |
10/17/2022 | $40.00 | Buy | Deutsche Bank |
9/28/2022 | Outperform → Perform | Oppenheimer | |
1/11/2022 | $57.00 → $63.00 | Equal-Weight | Morgan Stanley |
12/10/2021 | $62.00 → $65.00 | Overweight | Wells Fargo |
Deutsche Bank upgraded Avient from Hold to Buy and set a new price target of $52.00 from $49.00 previously
Deutsche Bank downgraded Avient from Buy to Hold and set a new price target of $37.00 from $46.00 previously
Oppenheimer upgraded Avient from Perform to Outperform and set a new price target of $50.00
8-K - AVIENT CORP (0001122976) (Filer)
10-Q - AVIENT CORP (0001122976) (Filer)
8-K - AVIENT CORP (0001122976) (Filer)
CLEVELAND, Sept. 5, 2024 /PRNewswire/ -- Avient Corporation (NYSE:AVNT) ("Avient") today announced the pricing of its previously announced offering of $650 million in aggregate principal amount of senior notes due 2031 (the "notes") in an offering exempt from the registration requirements of the Securities Act of 1933 (the "Securities Act"). The notes will bear interest at an annual rate of 6.250% and will be issued at a price of 100.000% of their principal amount. The closing of the notes offering is expected to occur on September 19, 2024, subject to customary closing conditions.
CLEVELAND, Sept. 5, 2024 /PRNewswire/ -- Avient Corporation (NYSE:AVNT) ("Avient") today announced the commencement of an offering of $650 million in aggregate principal amount of senior notes due 2031 (the "notes") in an offering exempt from the registration requirements of the Securities Act of 1933 (the "Securities Act"). Avient intends to use the net proceeds from the offering, together with cash on hand, to redeem all of its outstanding 5.75% senior notes due 2025 (the "2025 senior notes") and pay related fees and expenses. The notes will be offered only to persons reason
Second quarter sales grew to $850 million, a 3% increase over the prior year quarter and a 5% organic increase when excluding the impact of foreign exchangeSecond quarter GAAP EPS from continuing operations of $0.36 compared to $0.24 in the prior year quarterSecond quarter adjusted EPS of $0.76 exceeded guidance of $0.71 and increased 21% over prior year quarter, driven by organic revenue growth in all regions, favorable input costs and lower interest expenseIncreasing 2024 full-year adjusted EPS guidance range to $2.55 to $2.70, from prior guidance of $2.50 to $2.65 given strong second quarter results; Revised guidance reflects 8% to 14% growth in adjusted EPS over the prior year2023 Sustai
Sends Letter to Shareholders Reiterating Why Voting for Both Politan's "Highly Credible and Capable" Nominees Is Essential in Order to Safeguard Shareholder Value and Realize Masimo's Potential Highlights Key Facts Brought to Light During Discovery Process and Remains Confident That Masimo's Frivolous Legal Claims and Efforts to Reject Politan's Nomination Notice Will Be Defeated Shareholders Can Vote for Politan's Independent Nominees, Darlene Solomon and William Jellison, on the WHITE Card and Can Visit www.AdvanceMasimo.com for Further Information Politan Capital Management (together with its affiliates, "Politan"), an 8.9% shareholder of Masimo Corporation ("Masimo" or the "Compan
CLEVELAND, Sept. 5, 2024 /PRNewswire/ -- Avient Corporation (NYSE:AVNT) ("Avient") today announced the pricing of its previously announced offering of $650 million in aggregate principal amount of senior notes due 2031 (the "notes") in an offering exempt from the registration requirements of the Securities Act of 1933 (the "Securities Act"). The notes will bear interest at an annual rate of 6.250% and will be issued at a price of 100.000% of their principal amount. The closing of the notes offering is expected to occur on September 19, 2024, subject to customary closing conditions.
CLEVELAND, Sept. 5, 2024 /PRNewswire/ -- Avient Corporation (NYSE:AVNT) ("Avient") today announced the commencement of an offering of $650 million in aggregate principal amount of senior notes due 2031 (the "notes") in an offering exempt from the registration requirements of the Securities Act of 1933 (the "Securities Act"). Avient intends to use the net proceeds from the offering, together with cash on hand, to redeem all of its outstanding 5.75% senior notes due 2025 (the "2025 senior notes") and pay related fees and expenses. The notes will be offered only to persons reason
4 - AVIENT CORP (0001122976) (Issuer)
Cannabis producer Avant Brands Inc. (TSX:AVNT) (OTCQX:AVTBF) (FRA: 1BUP) reported its financial results on Monday for the second quarter ended May 31, 2024. The British Columbia-based company said in a press release that it has achieved "significant financial milestones driven by strategic international expansion and operational improvements." Q2 2024 Financial Highlights Gross revenue increased by 5% reaching CA$9.4 million ($6.8 million) compared to the second quarter of 2023, while net revenue rose by 4% over the same period to CA$8.3 million, demonstrating sustained growth driven by robust international demand. International sales rose 26% year-over-year to reach a record CA
Avient (NYSE:AVNT) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 3 0 0 0 Last 30D 1 1 0 0 0 1M Ago 0 2 0 0 0 2M Ago 0 0 0 0 0 3M Ago 0 0 0 0 0 Insights from analysts' 12-month price targets are revealed, presenting an average target of $51.0, a high estimate of $53.00, and a low estimate of $49.00. Surpassing the previous average price target of $47.25
Wells Fargo analyst Michael Sison maintains Avient (NYSE:AVNT) with a Overweight and raises the price target from $50 to $52.
SC 13G/A - AVIENT CORP (0001122976) (Subject)
SC 13G/A - AVIENT CORP (0001122976) (Subject)
SC 13G - AVIENT CORP (0001122976) (Subject)
4 - AVIENT CORP (0001122976) (Issuer)
4 - AVIENT CORP (0001122976) (Issuer)
4 - AVIENT CORP (0001122976) (Issuer)
Sends Letter to Masimo Shareholders and Releases 160-Page Investor Presentation Urges Shareholders to Help Deliver Immediate Change by Voting for Both of Politan's Independent and Ideally Qualified Nominees Darlene Solomon and William Jellison on the WHITE Card Shareholders Can Visit www.AdvanceMasimo.com for Further Information Politan Capital Management (together with its affiliates, "Politan"), an 8.9% shareholder of Masimo Corporation ("Masimo" or the "Company") (NASDAQ:MASI), today sent a letter to the Company's shareholders outlining why a majority of truly independent directors are urgently needed in the Masimo boardroom. Politan also released a detailed investor presentation m
Jamie A. Beggs and Scott A. Tozier to Join as Newest Board Members Ilene S. Gordon to Retire from the Board MEMPHIS, Tenn., May 22, 2024 /PRNewswire/ -- International Paper ("IP") (NYSE:IP) announced that Jamie A. Beggs and Scott A. Tozier have been elected to IP's Board of Directors, effective May 21, 2024. The company also announced that Ilene S. Gordon has retired from the Board citing personal and health reasons, effective May 21, 2024. Ms. Beggs, age 47, currently serves as Senior Vice President and Chief Financial Officer of Avient Corporation (NYSE:AVNT), a premier pr
Robert M. Patterson to Remain in an Advisory Role Until His Retirement on May 31, 2024 Richard H. Fearon Appointed Non-Executive Chairman of the Board CLEVELAND, Nov. 13, 2023 /PRNewswire/ -- Avient Corporation (NYSE:AVNT), a leading provider of specialized and sustainable material solutions, today announced that its Board of Directors has unanimously voted to elect Dr. Ashish K. Khandpur as President and Chief Executive Officer, effective December 1, 2023. In connection with this appointment, the Board has elected Richard H. Fearon, Lead Independent Director, as Non-Executive Chairman of the Board, also effective December 1, 2023.